Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.90
0.00 (0.00%)
At close: Aug 14, 2025, 4:00 PM
13.93
+0.03 (0.22%)
After-hours: Aug 14, 2025, 4:10 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $193.11 million as of August 14, 2025.
Market Cap
193.11M
Enterprise Value
196.52M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.90
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $219.43M to $193.11M, a decrease of -12.00%. That is a compound annual growth rate of -55.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 193.11M | -12.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |